Ignite Creation Date:
2025-12-24 @ 9:18 PM
Ignite Modification Date:
2026-02-21 @ 3:45 AM
Study NCT ID:
NCT02150304
Status:
COMPLETED
Last Update Posted:
2015-08-05
First Post:
2014-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Aminophylline Prophylaxis For Postdural Puncture Headache
Sponsor:
Diskapi Yildirim Beyazit Education and Research Hospital
Organization:
Study Overview
Official Title:
Phase IV Study of Intravenous Aminophylline During Spinal Anesthesia
Status:
COMPLETED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
postdural puncture headache is a rare but serious complication of spinal anesthesia. many drugs were studied in prevention or treatment of that complication. However, there are limited numbers of trials about intravenous aminophylline for prevention. because of that we retrospectively aimed to investigate the effectiveness of aminophylline for postdural puncture headache in cesarean section.
Detailed Description:
retrospective trial about the effect of intravenous aminophylline for prevention of PDPH after caserean section with spinal anesthesia
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: